AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.560
-0.040 (-1.54%)
Apr 25, 2025, 1:53 PM EDT - Market open
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $762.85 million as of April 25, 2025. Its market cap has decreased by -41.97% in one year.
Market Cap
762.85M
Enterprise Value
202.60M
1-Year Change
-41.97%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $762.85M, a decrease of -95.13%. That is a compound annual growth rate of -49.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 753.91M | -12.89% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 768.81B |
| UnitedHealth Group | 378.85B |
| Johnson & Johnson | 368.73B |
| AbbVie | 322.13B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.25B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |